Working… Menu

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00471653
Recruitment Status : Terminated (low accrual)
First Posted : May 10, 2007
Last Update Posted : July 9, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 12, 2008
Actual Study Completion Date : August 18, 2009